| Why drinking green tea could prevent cancer J Jankun, SH Selman, R Swiercz, E Skrzypczak-Jankun Nature 387, 561, 1997 | 1053 | 1997 |
| Curcumin inhibits lipoxygenase by binding to its central cavity: theoretical and X-ray evidence. E Skrzypczak-Jankun, NP McCabe, SH Selman, J Jankun International journal of molecular medicine 6 (5), 521-527, 2000 | 181 | 2000 |
| A study of the anti-diabetic agents of camel milk A Malik, A Al-Senaidy, E Skrzypczak-Jankun, J Jankun International journal of molecular medicine 30 (3), 585-592, 2012 | 154 | 2012 |
| In vivo and in vitro effect of baicalein on human prostate cancer cells. R Miocinovic, NP McCabe, RW Keck, J Jankun, JA Hampton, SH Selman International journal of oncology 26 (1), 241-246, 2005 | 144 | 2005 |
| Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers J Jankun, HW Merrick, PJ Goldblatt Journal of cellular biochemistry 53 (2), 135-144, 1993 | 133 | 1993 |
| Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice J Jankun, RW Keck, E Skrzypczak-Jankun, R Swiercz Cancer research 57 (4), 559-563, 1997 | 132 | 1997 |
| Structure of curcumin in complex with lipoxygenase and its significance in cancer E Skrzypczak-Jankun, K Zhou, NP McCabe, SH Selman, J Jankun International journal of molecular medicine 12, 17-24, 2003 | 131 | 2003 |
| Determining whether curcumin degradation/condensation is actually bioactivation J Jankun, M Wyganowska-Świątkowska, K Dettlaff, A Jelińska, ... International journal of molecular medicine 37 (5), 1151-1158, 2016 | 119 | 2016 |
| 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains DW BoMBICK, J Jankun, K Tullis, F Matsumura Proceedings of the National Academy of Sciences 85 (12), 4128, 1988 | 117 | 1988 |
| Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X‐ray structure at 2.1 Å resolution OY Borbulevych, J Jankun, SH Selman, E Skrzypczak‐Jankun Proteins: structure, function, and bioinformatics 54 (1), 13-19, 2004 | 109 | 2004 |
| Inhibition of lipoxygenase by (-)-epigallocatechin gallate: X-ray analysis at 2.1 Å reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead E Skrzypczak-Jankun, K Zhou, J Jankun Int. J. Mol. Med 12, 415-422, 2003 | 104 | 2003 |
| Plasminogen activator inhibitor-1 in kidney pathology S Małgorzewicz, E Skrzypczak-Jankun, J Jankun International journal of molecular medicine 31 (3), 503-510, 2013 | 96 | 2013 |
| Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride. J Jankun, E Skrzypczak-Jankun Cancer biochemistry biophysics 17 (1-2), 109-123, 1999 | 77 | 1999 |
| Human platelet 12-lipoxygenase, new findings about its activity, membrane binding and low-resolution structure AM Aleem, J Jankun, JD Dignam, M Walther, H Kühn, DI Svergun, ... Journal of molecular biology 376 (1), 193-209, 2008 | 76 | 2008 |
| Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator R Swiercz, E Skrzypczak-Jankun, MM Merrell, SH Selman, J Jankun Oncology reports 6, 523-526, 1999 | 74 | 1999 |
| Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells J Jankun, AM Aleem, S Malgorzewicz, M Szkudlarek, MI Zavodszky, ... Molecular cancer therapeutics 5 (5), 1371, 2006 | 72 | 2006 |
| Plasminogen activator inhibitor type-1: its structure, biological activity and role in tumorigenesis J Chorostowska-Wynimko, E Skrzypczak-Jankun, J Jankun Int J Mol Med 13 (6), 759-766, 2004 | 68 | 2004 |
| Clinical implications of the growth-suppressive effects of chlorhexidine at low and high concentrations on human gingival fibroblasts and changes in morphology M Wyganowska-Swiatkowska, M Kotwicka, P Urbaniak, A Nowak, ... International Journal of Molecular Medicine 37 (6), 1594-1600, 2016 | 67 | 2016 |
| Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice R Swiercz, RW Keck, E Skrzypczak-Jankun, SH Selman, J Jankun Oncology reports 8 (3), 463-470, 2001 | 67 | 2001 |
| A Novel Form of the Plasminogen Activator Inhibitor Created by Cysteine Mutations Extends Its Half-Life: Relevance to Cancer and Angiogenesis1 J Chorostowska-Wynimko, R Swiercz, E Skrzypczak-Jankun, A Wojtowicz, ... Molecular cancer therapeutics 2 (1), 19, 2003 | 65 | 2003 |
